nach oben

Current Oncology Reports

Erschienen in:

01.08.2012 | Lung Cancer (T Mekhail, Section Editor)

Thymic Neoplasms: a Clinical Update

verfasst von: Mark Mikhail, Yasmin Mekhail, Tarek Mekhail

Erschienen in: Current Oncology Reports | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Thymoma is a unique neoplasm of the anterior mediastinum that is frequently associated with indolent growth and a variety of paraneoplastic syndromes. One third of cases are detected during the evaluation of myasthenia gravis. Classification systems of thymoma have limited ability in accurately predicting prognosis and course of disease. Thus, staging is the only way to predict clinical behavior. Encapsulated tumors that are surgically resected carry the best prognosis. Adjuvant radiotherapy is recommended for incompletely excised and most invasive thymomas. Chemotherapy in anthracycline-based chemotherapy remains the most effective chemotherapy for neoadjuvant, adjuvant or palliative treatment.

Miller JF. Thymus and immunity–II. The last three decades. Eur J Cancer Clin Oncol. 1988;24(8):1257–62.PubMedCrossRef

Mller-Hermelink HK, Wilisch A, Schultz A, Marx A. Characterization of the human thymic microenvironment: lymphoepithelial interaction in normal thymus and thymoma. Arch Histol Cytol. 1997;60(1):9–28.CrossRef

Rosen FS. The primary immunodeficiencies. N Engl J Med. 1984;311(5):300.PubMedCrossRef

Thomas CR. Thymoma: State of the art. J Clin Oncol. 1999;17(7):2280.PubMed

Gerein AN. Thymoma: A ten year review. Am J Surg. 1978;136(1):49.PubMedCrossRef

Engels EA. Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer. 2003;105(4):546.PubMedCrossRef

Mullen B. Primary anterior mediastinal tumors in children and adults. Ann Thorac Surg. 1986;42:338–45.PubMedCrossRef

Wilkins Jr EW. Role of staging in prognosis and management of thymoma. Ann Thorac Surg. 1991;51(6):888.PubMedCrossRef

Loehrer Sr PJ. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. Cancer. 2001;91(11):2010.PubMedCrossRef

10.

Sperling B. Thymoma: A review of the clinical and pathological findings in 65 cases. Can J Surg. 2003;46(1):37.PubMed

11.

Blumberg D. Thymoma: A multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995;60(4):908.PubMedCrossRef

12.

Wang LS. Malignant thymoma. Cancer. 1992;70(2):443.PubMedCrossRef

13.

Wilkins KB. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg. 1999;230(4):562.PubMedCrossRef

14.

Froudarakis ME. Invasive thymoma: A clinical study of 23 cases. Respiration. 2000;68(4):376.CrossRef

15.

Fujimura S. Results of surgical treatment for thymoma based on 66 patients. J Thorac Cardiovasc Surg. 1987;93(5):708.PubMed

16.

Do Y. CT findings in malignant tumors of thymic epithelium. J Comput Assist Tomogr. 1995;19(2):192.PubMedCrossRef

17.

van de Wijngaert FP, Kendall MD, Schuurman HJ, Rademakers LH, Kater L. Heterogeneity of epithelial cells in the human thymus. An ultrastructural study. Cell Tissue Res. 1984;237(2):227–37.PubMedCrossRef

18.

Marino M. Thymoma and thymic carcinoma. Virchows Arch. 1985;407(2):119–49.CrossRef

19.

Wick MR. Primary thymic carcinomas. Am J Surg Pathol. 1982;6(7):613.PubMedCrossRef

20.

Rios A. Prognostic factors in thymic epithelial neoplasms. Eur J Cardiothorac Surg. 2002;21(2):307.PubMedCrossRef

21.

Sassa, Mizushima Y, Kusajima Y, Sugiyama S, Noto H, Kobayashi M. Clinical study on thymoma: Assessment of prognostic factors. Anticancer Res. 1996;16(6B):3895–900.

22.

Lardinois D. Prognostic relevance of masaoka and MÃƒÂ¼ller-hermelink classification in patients with thymic tumors. Ann Thorac Surg. 2000;69(5):1550.PubMedCrossRef

23.

Latz D. Invasive thymoma: Treatment with postoperative radiation therapy. Radiology. 1997;204(3):859.PubMed

24.

Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004;77(4):1183–8. 4.PubMedCrossRef

25.

Mayer R. Radiotherapy for invasive thymoma and thymic carcinoma. Strahlenther Onkol. 1999;175(6):271.PubMedCrossRef

26.

Allen MS. Benign mediastinal germ cell tumors. In: Wood DE, Thomas CR, editors. Mediastinal Tumors: Update 1995. Springer-Verlag; 1995. p. 37–42.

27.

Zhang Z, Ren H, Yu H, Li Z, Liu H, Lu Z. Thymic carcinoid tumor–a report of 7 cases. Chin Med Sci J. 1993;8(1):48–51.PubMed

28.

Economopoulos GC. Carcinoid tumors of the thymus. Ann Thorac Surg. 1990;50(1):58.PubMedCrossRef

29.

Asbun HJ, Calabria RP, Calmes S, Lang AG, Bloch JH. Thymic carcinoid. Am Surg. 1991;57(7):442–5.PubMed

30.

Falkson CB. The management of thymoma: A systematic review and practice guideline. J Thorac Oncol. 2009;4(7):911.PubMedCrossRef

31.

Strollo DC. Primary mediastinal tumors. part 1. Chest. 1997;112(2):511.PubMedCrossRef

32.

Wick MR. Primary mediastinal carcinoid tumors. Am J Surg Pathol. 1982;6(3):195.PubMedCrossRef

33.

Gray GF. Thymoma. A clinicopathologic study of 54 cases. Am J Surg Pathol. 1979;3(3):235.PubMedCrossRef

34.

Lattes R. Thymoma and other tumors of the thymus. An analysis of 107 cases. Cancer. 1962;15(6):1224.CrossRef

35.

Lewis JE. Thymoma. A clinicopathologic review. Cancer. 1987;60(11):2727.

36.

Rubin M. Clinical disorders associated with thymic tumors. Arch Intern Med. 1964;114(3):389.PubMedCrossRef

37.

Weissberg D. Thymoma. Ann Thorac Surg. 1973;16(2):141.PubMedCrossRef

38.

Masaoka A. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48(11):2485.PubMedCrossRef

39.

Bernatz PE, Harrison EG, Clagett OT. Thymoma: A clinicopathologic study. J Thorac Cardiovasc Surg. 1961;42:424–44.PubMed

40.

Kirchner T, Muller-Hermelink HK. New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol. 1989;10:167–89.

41.

Cornea R, Cimpean AM, Raica M. World health organization histo-morphologic classification of thymomas. pros and cons. TMJ. 2009;59(3–4):371–7.

42.

Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg. 2006;81(6):2328.PubMedCrossRef

43.

Verley JM. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer. 1985;55(5):1074.PubMedCrossRef

44.

Sawyers JL. Surgical treatment of thymomas. Arch Surg. 1968;96(5):814.PubMedCrossRef

45.

Bernatz P, Khonsari S, Harrison E, Taylor W. Thymoma: Factors influencing prognosis. Surg Clin North Am. 1973;53(4):885–92. 08.PubMed

46.

Levine GD. Thymic hyperplasia and neoplasia: A review of current concepts. Hum Pathol. 1978;9(5):495.PubMedCrossRef

47.

Batata MA. Thymomas: Clinicopathologic features, therapy, and prognosis. Cancer. 1974;34(2):389.PubMedCrossRef

48.

Legg MA. Pathology and clinical behavior of thymomas. A survey of 51 cases. Cancer. 1965;18(9):1131.PubMedCrossRef

49.

Singhal S, Shrager JB, Rosenthal DI, LiVolsi VA, Kaiser LR. Comparison of stages I–II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg. 2003;76(5):1635–42. 11.PubMedCrossRef

50.

Mangi AA, Wright CD, Allan JS, Wain JC, Donahue DM, Grillo HC, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg. 2002;74(4):1033–7. 10.PubMedCrossRef

51.

Mangi AA, Wain JC, Donahue DM, Grillo HC, Mathisen DJ, Wright CD. Adjuvant radiation of stage III thymoma: Is it necessary? Ann Thorac Surg. 2005;79(6):1834–9. 6.PubMedCrossRef

52.

Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg. 2004;77(5):1860–9. 5.PubMedCrossRef

53.

Verstandig AG, Epstein DM, Miller WT, Aronchik JA, Gefter WB. Thymoma–report of 71 cases and a review. Crit Rev Diagn Imaging. 1992;33(3):201–30.PubMed

54.

Lewis BD. Benign teratomas of the mediastinum. J Thorac Cardiovasc Surg. 1983;86(5):727.PubMed

55.

Armstrong P. Mediastinal and hilar disorders. In: Armstrong P, Wilson AG, Dee P, Hansell DM, editors. Imaging of Diseases of the Chest. London: Mosby; 2000. p. 789–949.

56.

Regnard JF. Prognostic factors and long-term results after thymoma resection: A series of 307 patients. J Thorac Cardiovasc Surg. 1996;112(2):376.PubMedCrossRef

57.

O'Gara RW. Tumors of the anterior mediastinum. Cancer. 1958;11(3):562.PubMedCrossRef

58.

Salyer WR. Thymoma. A clinical and pathological study of 65 cases. Cancer. 1976;37(1):229.PubMedCrossRef

59.

Wilkins Jr EW. Cases of thymoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg. 1966;52(3):322.PubMed

60.

Legolvan DP. Thymomas. Cancer. 1977;39(5):2142.PubMedCrossRef

61.

Moore KH. Thymoma: Trends over time. Ann Thorac Surg. 2001;72(1):203.PubMedCrossRef

62.

Gawrychowski J. Thymoma–the usefulness of some prognostic factors for diagnosis and surgical treatment. Eur J Surg Oncol. 2000;26(3):203.PubMedCrossRef

63.

Haniuda M. Recurrence of thymoma: Clinicopathological features, re-operation, and outcome. J Surg Oncol. 2001;78(3):183.PubMedCrossRef

64.

Maggi G. Thymoma: Results of 241 operated cases. Ann Thorac Surg. 1991;51(1):152.PubMedCrossRef

65.

Matsushima S, Yamamoto H, Egami K, Suzuki S, Tanaka S. Evaluation of the prognostic factors after thymoma resection. Int Surg. 2001;86(2):103–6.

66.

Nakahara K. Thymoma: Results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg. 1988;95(6):1041.PubMed

67.

Okumura M. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg. 1999;117(3):605.PubMedCrossRef

68.

Sakai S. Differential diagnosis between thymoma and non-thymoma by dynamic MR imaging. Acta Radiol. 2002;43(3):262.PubMedCrossRef

69.

Maher MM. Imaging of thymoma. Semin Thorac Cardiovasc Surg. 2005;17(1):12.PubMedCrossRef

70.

Rosado-de-Christenson ML. Thymoma: Radiologic-pathologic correlation. Radiographics. 1992;12(1):151.PubMed

71.

Jeong YJ, Does CT. of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR. Am J Roentgenol. 2004;183(2):283.

72.

Kubota K. PET imaging of primary mediastinal tumours. Br J Cancer. 1996;73(7):882.PubMedCrossRef

73.

Sasaki M. Differential diagnosis of thymic tumors using a combination of 11 C-methionine PET and FDG PET. J Nucl Med. 1999;40(10):1595.PubMed

74.

Liu RS. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report. Eur J Nucl Med. 1995;22(12):1402.PubMedCrossRef

75.

Curran Jr W, Kornstein M, Brooks J, Turrisi A. Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 1988;6(11):1722–7.PubMed

76.

Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y, et al. Recurrence of thymoma: Clinicopathological features, therapy, and prognosis. Ann Thorac Surg. 1985;39(2):165–9.PubMedCrossRef

77.

Haniuda M, Morimoto M, Nishimura H, Kobayashi O, Yamanda T, Iida F. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg. 1992;54(2):311–5.PubMedCrossRef

78.

Haniuda M, Miyazawa M, Yoshida K, Oguchi M, Sakai F, Izuno I, et al. Is postoperative radiotherapy for thymoma effective? Ann Surg. 1996;224(2):219.PubMedCrossRef

79.

Fornasiero A, Daniele O, Ghiotto C, Fiorentino MV, Piazza M, Fiore-Donati L, et al. Chemotherapy for invasive thymoma. A 13–year experience. Cancer. 1991;68(1):30–3.PubMedCrossRef

80.

Loehrer Sr PJ, Kim KM, Aisner SC, Livingston R, Einhorn LH, Johnson D, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an intergroup trial. The eastern cooperative oncology group, southwest oncology group, and southeastern cancer study group. J Clin Oncol. 1994;12(6):1164–8.PubMed

81.

Pj SL, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial. J Clin Oncol. 1997;15(9):3093–9.

82.

Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk N. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European organization for research and treatment of cancer lung cancer cooperative group. J Clin Oncol. 1996;14(3):814–20.PubMed

83.

Grassin F, Paleiron N, André M, Caliandro R, Bretel JJ, P Terrier, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience. J Thorac Oncol. 2010;5(6):893.PubMedCrossRef

84.

Lemma GL, Lee JW, Aisner SC, Langer CJ, Tester WJ, Johnson DH, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol. 2011;29(15):2060–5.PubMedCrossRef

85.

Ito J, Sekiya M, Miura K, Yoshimi K, Suzuki T, Seyama K, et al. Refractory recurrent thymoma successfully treated with long-acting somatostatin analogue and prednisolone. Intern Med. 2009;48(12):1061–4.PubMedCrossRef

86.

Loehrer Sr PJ, Wang W, Johnson DH, Ettinger DS. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An eastern cooperative oncology group phase II trial. J Clin Oncol. 2004;22(2):293–9.PubMedCrossRef

87.

Pettit L, El-Modir A. The role of somatostatin analogues in the treatment of advanced malignant thymomas: Case report and review of the literature. Br J Radiol. 2011;84(997):e7–10.PubMedCrossRef

88.

Souadjian JV, Enriquez P, Silverstein MN, Ppin JM. The spectrum of diseases associated with thymoma. coincidence or syndrome? Arch Intern Med. 1974;134(2):374–9.PubMedCrossRef

89.

Morgenthaler TI. Thymoma. Mayo Clin Proc. 1993;68(11):1110.PubMed

90.

Maggi G. Thymomas: A review of 169 cases, with particular reference to results of surgical treatment. Cancer. 1986;58(3):765.PubMedCrossRef

91.

Wright M. Mediastinal tumors: Diagnosis and treatment. World J Surg. 2001;25(2):204.PubMedCrossRef

92.

Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330(25):1797–810. 06/23.PubMedCrossRef

93.

Kirchner T. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol. 1992;16(12):1153.PubMedCrossRef

94.

Marx A. Pathogenesis of myasthenia gravis. Virchows Arch. 1997;430(5):355.PubMedCrossRef

95.

Blossom GB. Thymectomy for myasthenia gravis. Arch Surg. 1993;128(8):855.PubMedCrossRef

96.

Sellors TH. Tumours of the thymus. Thorax. 1967;22(3):193.PubMedCrossRef

97.

Wilkins Jr EW. Thymoma: A continuing survey at the Massachusetts General Hospital. Ann Thorac Surg. 1979;28(3):252.PubMedCrossRef

98.

Slater G. Thymomas in patients with myasthenia gravis. Ann Surg. 1978;188(2):171.PubMedCrossRef

99.

Bergh NP. Tumors of the thymus and thymic region: I. clinicopathological studies on thymomas. Ann Thorac Surg. 1978;25(2):91.PubMedCrossRef

100.

Waldmann TA. Thymoma, hypogammaglobulinemia and absence of eosinophils. J Clin Invest. 1967;46:1127.CrossRef

101.

Kumura J. Post-thymectomy myasthenia gravis: Report a case of ocular myasthenia gravis after total removal of a thymoma and review of the literature. Neurology. 1967;17:413.CrossRef

102.

Wick MR, Rosai J. The endocrine thymus. In: Kovac K, Asa SI, editors. Functional Endocrine Pathology, vol. 2. Boston: Blackwell Scientific; 1991. p. 790–813.

103.

Rosai J, Higa E. Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. clinicopathologic study of 8 cases. Cancer. 1972;29(4):1061–74.PubMedCrossRef

104.

Wick M, Scott R, Li CY, Carney J. In: Carcinoid tumor of the thymus: A clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc. 1980;55(4):246–54.

105.

Sugiura H, Morikawa T, Itoh K, Ono K, Okushiba S, Kondo S, et al. Thymic carcinoid in a patient with multiple endocrine neoplasia type 1: Report of a case. Surg Today. 2001;31(5):428–32.PubMedCrossRef

106.

Teh B. Thymic carcinoids in multiple endocrine neoplasia type 1. J Intern Med. 1998;243(6):501–4.PubMedCrossRef

Titel: Thymic Neoplasms: a Clinical Update
verfasst von: Mark Mikhail
Yasmin Mekhail
Tarek Mekhail
Publikationsdatum: 01.08.2012
Verlag: Current Science Inc.
Erschienen in: Current Oncology Reports / Ausgabe 4/2012
Print ISSN: 1523-3790
Elektronische ISSN: 1534-6269
DOI: https://doi.org/10.1007/s11912-012-0246-8

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Thymic Neoplasms: a Clinical Update

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Advances in Adjuvant Therapy of Gastrointestinal Stromal Tumors

Incidence and Management of Gastrointestinal Perforation from Bevacizumab in Advanced Cancers

VEGF Inhibition, Hypertension, and Renal Toxicity

Progress in Radiotherapy for Pediatric Sarcomas

The Double Edged Sword of Bleeding and Clotting from VEGF Inhibition in Renal Cancer Patients

Management of Non-Small Cell Lung Cancer with Oligometastasis

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie